CD274 and neoplasm: Specifically, for the 41 patients with positive PD-L1 status (tumor proportion score (TPS) ≥ 1%), the patients with high EGFR-DLS had a low DCB rate of 54.54% and a high hyperprogression rate of 18.18% vs 76.67% and 6.67% in the patients with low EGFR-DLS.